Jazz Pharmaceuticals plc (65) | Business Finance (13)
Browse by Subcategory
Recent Contracts
-
Description of Share Capital
(Filed With SEC on March 1, 2022)
-
First Supplemental Indenture, dated as of July 21
(Filed With SEC on August 3, 2021)
-
Participation Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited
(Filed With SEC on August 3, 2021)
-
Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan
(Filed With SEC on November 2, 2020)
-
Indenture, dated as of April 29, 2021, by and among Jazz Securities Designated Activity Company, the guarantors party thereto, U.S. Bank National Association, as trustee and U.S....
(Filed With SEC on April 29, 2021)
-
Description of Share Capital
(Filed With SEC on February 23, 2021)
-
Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007...
(Filed With SEC on November 2, 2020)
-
Amended and Restated 2007 Non-Employee Directors Stock Award Plan (approved July 30, 2020)
(Filed With SEC on August 4, 2020)
-
Indenture, dated as of June 11, 2020 among Jazz Pharmaceuticals Public Limited Company, Jazz Investments I Limited and U.S. Bank National Association
(Filed With SEC on June 11, 2020)
-
Description of Share Capital
(Filed With SEC on February 25, 2020)
-
Change in Control Stock Award Acceleration Agreement, dated as of May 15, 2016 by and between Jazz Pharmaceuticals plc and Patricia Carr
(Filed With SEC on November 5, 2019)
-
Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan
(Filed With SEC on May 7, 2019)
-
Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007...
(Filed With SEC on May 7, 2019)